Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Réjean Ruel

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Organic Letters|December 20, 2003
Concise and efficient synthesis of 4-fluoro-1H-pyrrolo[2,3-b]pyridineCarl Thibault, Alexandre L'Heureux, Rajeev S Bhide, et al.
Nature Methods|February 25, 2014
Identification of small molecules that support human leukemia stem cell activity ex vivoCaroline Pabst, Jana Krosl, Iman Fares, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 20, 2024
Structure-based design of small molecule inhibitors of the cagT4SS ATPase Cagα of <i>Helicobacter pylori</i>Claire Morin, Vijay Tailor Verma, Tarun Arya, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2013
New azole antagonists with high affinity for the P2Y(1) receptorRéjean Ruel, Alexandre L'Heureux, Carl Thibeault, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Chemogenomic Landscape of <i>RUNX1</i>-mutated AML Reveals Importance of <i>RUNX1</i> Allele Dosage in Genetics and Glucocorticoid SensitivityLaura Simon, Vincent-Philippe Lavallée, Marie-Eve Bordeleau, et al.
ACS Chemical Biology|April 25, 2023
Discovery of Benzodiazepine-Based Inhibitors of the E2 Enzyme UBCH10 from a Cell-Based p21 Degradation ScreenBenoit Pelletier, Stéphanie Duhamel, Guillaume Tambutet, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
beta-alanine dipeptides as MC4R agonistsRéjean Ruel, Timothy F Herpin, Lawrence Iben, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2013
Potent P2Y1 urea antagonists bearing various cyclic amine scaffoldsRéjean Ruel, Alexandre L'Heureux, Carl Thibeault, et al.
Science Advances|March 22, 2024
<i>SF3B1</i> mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemiaCéline Moison, Deanne Gracias, Julie Schmitt, et al.
EMBO Reports|April 28, 2025
DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibitionCéline Moison, Rodrigo Mendoza-Sanchez, Deanne Gracias, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Organic Letters|December 20, 2003
Concise and efficient synthesis of 4-fluoro-1H-pyrrolo[2,3-b]pyridineCarl Thibault, Alexandre L'Heureux, Rajeev S Bhide, et al.
Nature Methods|February 25, 2014
Identification of small molecules that support human leukemia stem cell activity ex vivoCaroline Pabst, Jana Krosl, Iman Fares, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 20, 2024
Structure-based design of small molecule inhibitors of the cagT4SS ATPase Cagα of <i>Helicobacter pylori</i>Claire Morin, Vijay Tailor Verma, Tarun Arya, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2013
New azole antagonists with high affinity for the P2Y(1) receptorRéjean Ruel, Alexandre L'Heureux, Carl Thibeault, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Chemogenomic Landscape of <i>RUNX1</i>-mutated AML Reveals Importance of <i>RUNX1</i> Allele Dosage in Genetics and Glucocorticoid SensitivityLaura Simon, Vincent-Philippe Lavallée, Marie-Eve Bordeleau, et al.
ACS Chemical Biology|April 25, 2023
Discovery of Benzodiazepine-Based Inhibitors of the E2 Enzyme UBCH10 from a Cell-Based p21 Degradation ScreenBenoit Pelletier, Stéphanie Duhamel, Guillaume Tambutet, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
beta-alanine dipeptides as MC4R agonistsRéjean Ruel, Timothy F Herpin, Lawrence Iben, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2013
Potent P2Y1 urea antagonists bearing various cyclic amine scaffoldsRéjean Ruel, Alexandre L'Heureux, Carl Thibeault, et al.
Science Advances|March 22, 2024
<i>SF3B1</i> mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemiaCéline Moison, Deanne Gracias, Julie Schmitt, et al.
EMBO Reports|April 28, 2025
DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibitionCéline Moison, Rodrigo Mendoza-Sanchez, Deanne Gracias, et al.
Pageof 2